ReviewReviews in urology2017

Active Surveillance Use Among a Low-risk Prostate Cancer Population in a Large US Payer System: 17-Gene Genomic Prostate Score Versus Other Risk Stratification Methods.

Steven Canfield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.